Riskpilot← Back to searchSign inGet full accessBERGEN REVMATOLOGISENTER AS
ASActiveOrg 916777345Bryggen 13, 5003 BergenMedical specialists activities · NACE 8622Est. 20165 employees
Revenue 2024
NOK 6,5M
-1% vs 2023
EBITDA margin
53.7%
-8% vs 2023
Equity ratio
76.1%
Financial strength
Net profit 2024
NOK 2,6M
-9% vs 2023
| Revenue | NOK 6,5M | -1% |
| EBITDA | NOK 3,5M | -8% |
| Net profit | NOK 2,6M | -9% |
| Total assets | NOK 5M | -10% |
| Equity | NOK 3,8M | +27% |
| Employees | 5 | — |
Legal name
BERGEN REVMATOLOGISENTER AS
Org number
916777345
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
22. februar 2016
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet innen revmatologi.
Address
Bryggen 13, 5003 Bergen
Phone
+4755900070
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 883 | 5 938 | 6 340 | 6 556 | 6 495 |
| Staff expenses | −1 456 | −1 540 | −1 710 | −1 873 | −2 015 |
| EBITDA | 2 564 | 3 629 | 3 747 | 3 806 | 3 490 |
| Depreciation & amort. | −28 | −49 | −89 | −94 | −98 |
| EBIT | 2 536 | 3 580 | 3 658 | 3 712 | 3 393 |
| Net financials | −9 | −1 | −1 | −3 | −1 |
| Profit before tax | 2 527 | 3 580 | 3 658 | 3 708 | 3 391 |
| Tax | 560 | 790 | 813 | 818 | 750 |
| Net profit | 1 967 | 2 790 | 2 845 | 2 890 | 2 641 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 389 | 5 446 | 5 295 | 5 616 | 5 030 |
| Equity | 3 551 | 74 | 119 | 3 009 | 3 830 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 837 | 5 372 | 5 176 | 2 608 | 1 201 |
| Total debt | 837 | 5 372 | 5 176 | 2 608 | 1 201 |
EBITDA margin
53.7%
This company
15.8%
Market median
+240% vs market
20202024
Equity ratio
76.1%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
69.0%
This company
18.4%
Market median
+275% vs market
20202024
Net profit margin
40.7%
This company
8.1%
Market median
+402% vs market
20202024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BERGEN REVMATOLOGISENTER AS 
BERGEN SPESIALISTSENTER ASBoard members of BERGEN REVMATOLOGISENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victoria Margareta Barkovskij-Jakobsen | Board of Directors | 0 companies |
| Liv Bente Jakobsen | Chairman | 0 companies |
| Katarina Sofia Barkovskij-Jakobsen | Board of Directors | 0 companies |